Cor Vasa 2009, 51(9):567-571 | DOI: 10.33678/cor.2009.140
Heparin resistance and its incidence in patients undergoing on-pump surgery
- 1 Kardiochirurgická klinika, Fakultní nemocnice Hradec Králové a Lékařská fakulta Univerzity Karlovy, Hradec Králové
- 2 Kardiochirurgická klinika, Fakultní nemocnice Olomouc a Lékařská fakulta Univerzity Palackého, Olomouc
- 3 Chirurgická klinika, Fakultní nemocnice Hradec Králové a Lékařská fakulta Univerzity Karlovy, Hradec Králové, Česká republika
Aim: To determine the real incidence of heparin resistance in patients scheduled for a cardiac surgical procedure. To determine whether there is an association between preoperative treatment with heparin and the incidence of heparin resistance. Also, to establish whether there is an association between platelet count, patients' age, and heparin resistance.
Patients and methods: A total of 624 patients scheduled for on-pump surgery were included into a prospective study over a period of three years. Preoperative and intraoperative activated clotting time (ACT) values were recorded. Additionally, four factors referred to in the relevant literature as potential causes of developing heparin resistance were monitored in all patients: age 65 years, preoperative platelet count ≥ 300 × 109/l, preoperative administration of various types of heparin, antithrombin concentration ≤ 60%, and a combination of all. Patients were considered heparin-resistant if a heparin dose ≥ 5 mg/kg had not produced an anticoagulation response with ACT ≥ 480 s. Our data were evaluated using the test of agreement of relative frequency and the χ2 test.
Results: In our group, heparin resistance was detected in 203 of the 624 patients (32.5%). The incidence of heparin resistance differed significantly from the anticipated 22%. Among the 624 patients, 363 (58.2%) were older than 65 years. The hypothesis of age-dependence ≥ 65 years is rejected (p = 0.0391) or is of bordeline statistical significance. Regarding preoperative platelet count higher than 300 × 109/l, the hypothesis of independence was tested as opposed to the hypothesis of dependence. The hypothesis of independence was rejected (p = 0.000027). Before surgery, heparin was administered to 181 patients (29%). The hypothesis of dependence was tested as opposed to the alternative hypothesis of independence. The independence hypothesis was rejected (p < 0.001). Regarding preoperative antithrombin levels ≤ 60%, the hypothesis of independence was tested as opposed to the alternative hypothesis of independence. The hypothesis of independence of heparin resistance on antithrombin levels ≤ 60% was rejected (p < 0.001).
Conclusion: Results of our study have confirmed an incidence of heparin resistance significantly higher than anticipated. Furthermore, our results have confirmed the incidence of heparin resistance to depend significantly on the tested risk factors, except for patients' age, which was of bordeline statistical significance.
Keywords: Heparin resistance; Heparin; Antithrombin; ACT; Extracorporeal circulation; Platelets
Published: September 1, 2009 Show citation
References
- Staples M, Dunton R, Karlson K, et al. Heparin resistance after preoperative heparin therapy on intraaortic balloon pumping. Ann Thorac Surg 1994;57: 1211-6.
Go to original source...
- Bull MH, Huse WM, Bul BS. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. Anestesiology 1975;43:346-53.
Go to original source...
Go to PubMed...
- Bull BS, Huse WM, Bauer FS, et al. Heparin therapy during extracorporeal circulation II. The use of a dose - response curve to individualize heparin and protamin dosage. J Thorac Cardiovasc Surg 1975;69:685-9.
Go to original source...
- Bull BS, Korpmann RA, Huse W, et al. Heparin therapy during extracorporeal circulation. Problems inherent existing heparin protocols. J Thorac Cardiovasc Surg 1975;69:674-84.
Go to original source...
- Cloyd G, D'Ambra M, Akins C. Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;57:1211-6.
- Lonský V. Mimotělní oběh v klinické praxi. Praha: Grada Publishing, a. s., 2004:138.
- Lemmer JH, Jr, Despotis GJ. Antithrombin III concentrate to treat heparin stance in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2002;123:213-7.
Go to original source...
- Crutchfield DB. Low-Molecular-Weight Heparins. Geriatric Times 2002;III:1.
- Hořejší J, Sechser T. Nízkomolekulární versus nefrakciovaný heparin? Farmakologický pohled. Remedia 1996;6:232-5.
- Beholz S, Grubitzsch S, Berbmann B. Anticoagulation in extracorporeal circulation using recombinant hirudin: a case report. Perfusion 2000;15: 257-60.
Go to original source...
Go to PubMed...
- Fernandes P, Mayer R, Macdonald JL, et al. Use of danaparoid sodium (Organan®) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases. Perfusion 2000;15:531-9.
Go to original source...
Go to PubMed...
- Chlumský J a kol. Antikoagulační léčba. Praha: Grada Publishing, a. s., 2005:219.
- Kubisz P a kol. Hematológia a transfuziológia. Praha: Grada Publishing, a. s., 2006:323.
- Raymond PD, Ray MJ, Allen SN, et al. Heparin monitoring during cardiac surgery. Part 1: validation of whole-blood heparin concentration and activated clotting time. Perfusion 2003;18:269-76.
Go to original source...
Go to PubMed...
- Isgró G, Cazzaniga A, Soro G, et al. Predictors for heparin stance in patients undergoing coronary artery bypass grafting. Perfusion 1999;14:437-42.
Go to original source...
Go to PubMed...
- Chan T, Hwang NC, Lim CH. A statistical analysis of factors predisposing patiens to heparin stance. Perfusion 2006;21:99-103.
Go to original source...
Go to PubMed...
- Wendel HP, Philips A, Weber N, et al. Oxygenator thrombosis: worst case after development of an abnormal pressure gradient-incidence and pathway. Perfusion 2001;16: 271-7.
Go to original source...
Go to PubMed...
- Gibbon JH. Application of a mechanical heart lung apparatus to cardiac surgery. Minn Med 1954;37:171-80.
Go to PubMed...
- Dulíček P, Malý J, Pecka M, a spol. Možnosti a úskalí monitorování antikoagulační terapie heparinem. Lékařské zprávy 2003;48(1-2):72-3.
- Colman RW, Hirsh J, Marder VJ, et al. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: J. B. Lippincott Company, 1996:1260.